TrialJournal of diabetes investigation2026

A phase 1 single and multiple ascending dose study of orforglipron in Japanese participants with type 2 diabetes.

Kenji Ohwaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.